Product Information
M-PAP 160 MG/5 ML LIQUID is a generic product labeled by Method Pharmaceuticals LLC, priced at $0.0107 per ML under NDC 58657052516. Its NADAC has been published 365 times since Oct 9, 2019.
Strength
160 mg/5mL
Manufacturer
Method Pharmaceuticals LLCNDC
58657052516
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
8/1/2019
Price Statistics
The NADAC for M-PAP 160 MG/5 ML LIQUID has been published 365 times since Oct 9, 2019, and over the history we have for it it has risen 25.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0107 per ML |
|---|---|
| All-time high | $0.0190 (Mar 11, 2020) |
| All-time low | $0.0072 (Feb 22, 2023) |
| 52-week high | $0.0143 |
| 52-week low | $0.0107 |
| Median price | $0.0117 |
| Average price | $0.0120 |
| Largest weekly change | +81.2% (Feb 17, 2021) |
| Weeks tracked | 365 |
| Tracking since | Oct 9, 2019 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Method Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of M-PAP 160 MG/5 ML LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for M-PAP 160 MG/5 ML LIQUID, manufactured by Method Pharmaceuticals LLC, is $0.0107 per ML (NDC 58657052516), effective Sep 30, 2026.
How has the price of M-PAP 160 MG/5 ML LIQUID changed over time?
Over the history we have for it, the NADAC for M-PAP 160 MG/5 ML LIQUID has risen 25.8%. It has been tracked across 365 weekly CMS publications since Oct 9, 2019.
What are the highest and lowest recorded NADAC prices for M-PAP 160 MG/5 ML LIQUID?
Since Oct 9, 2019, the NADAC for M-PAP 160 MG/5 ML LIQUID has ranged from a low of $0.0072 (Feb 22, 2023) to a high of $0.0190 (Mar 11, 2020), with a median of $0.0117 per ML.
Are there cheaper alternatives to M-PAP 160 MG/5 ML LIQUID?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as M-PAP 160 MG/5 ML LIQUID in a comparable dosage form, but none are currently priced below it.
Who manufactures M-PAP 160 MG/5 ML LIQUID?
M-PAP 160 MG/5 ML LIQUID (NDC 58657052516) is labeled by Method Pharmaceuticals LLC, and CMS classifies it as a generic product.